Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients Mar 28, 2019 8:00am EDT
Molecular Templates to Present a Corporate Overview at the Cowen & Company 39th Annual and the Oppenheimer & Co. 29th Annual Health Care Conferences Mar 05, 2019 4:30pm EST
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019 Feb 27, 2019 5:00pm EST
Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer Feb 19, 2019 4:30pm EST
Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences Nov 26, 2018 4:30pm EST
Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update Nov 13, 2018 4:30pm EST
Study on Molecular Templates’ PD-L1 ETB with Antigen Seeding Technology Presented at SITC Annual Meeting Nov 09, 2018 8:00am EST
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Healthcare Conferences Sep 26, 2018 8:00am EDT
Molecular Templates, Inc. Announces Closing of Public Offering of Common Stock and the Full Exercise of the Underwriters’ Option to Purchase Additional Shares Sep 25, 2018 4:30pm EDT
Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock Sep 20, 2018 8:41pm EDT
